← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Revenue increased 40.2% to $8.45B, while Net income decreased 1.1% to $961.8M.
The read at a glance✓ Audited against SEC data
- Scale — FY2025 revenue $8.45BOK
- Profitability — Net income $961.8MOK
- Cash generation — Free cash flow $2.44BOK
- Accounting — No applicable forensic screenNote
- Insiders — 0 buys; 0 sells in 365 daysNote
- Capital — dividends paid were $1.88BNote
Business
WELLTOWER INC.: Through our disciplined approach to capital allocation powered by our Data Science platform and superior operating results driven by the Welltower Business System - our end-to-end platform - we aspire to deliver long-term compounding of per share growth for our existing investors.
Where the revenue comes from
Fiscal 2025, as WELLTOWER INC. reports it. History and quarterly detail are in the app.
- Seniors Housing Operating$8.5B
- Triple-net$1.2B
- Outpatient Medical$781.9M
Leadership changes
From WELLTOWER INC.'s own filings, the day they're filed.
- Nikhil Chaudhri · President · appointmenteff. 2025-01-02
- Tim McHugh · President · appointmenteff. 2025-01-02
- Diana W. Reid · Directors · departureeff. 2024-12-03
Latest filings
- 10-Q · Quarterly report2026-07-28
- 8-K · Company announcement2026-07-28
- 8-K · Company announcement2026-07-27
- 8-K · Company announcement2026-07-13
- 8-K · Company announcement2026-06-01
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about WELLTOWER INC., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.